PULMORIL-LS
Description
- Triple combination therapy for productive cough
- Levosalbutamol: Relieves bronchospasm and improves breathing
- Guaiphenesin: Loosens and expels mucus from the airways
- Ambroxol: Breaks down thick phlegm and enhances mucus clearance
- Ideal for bronchitis, asthma, COPD, and respiratory infections
- Quick onset of action and long-lasting relief
- Suitable for all age groups under medical guidance
Composition
LEVOSOLBUTAMOL-0.25 MG, GUAIPHENECIN- 12.5 MG, AMBROXOL-7.5 MG
Benefits
PULMORIL-LS offers comprehensive relief from wet cough, chest congestion, and breathing difficulties. Levosalbutamol ensures quick and sustained bronchodilation, improving airflow and reducing wheezing. Guaiphenesin facilitates the easy removal of mucus, helping to clear the airways, while Ambroxol enhances the effectiveness of mucociliary clearance. This triple-action formula not only soothes cough but also promotes faster recovery from respiratory illnesses. It is well-tolerated and suitable for pediatric and adult patients, as directed by a healthcare professional.
Introduction
PULMORIL-LS is a synergistic respiratory syrup formulated with Levosalbutamol, Guaiphenesin, and Ambroxol to provide effective relief from productive cough and respiratory congestion. Levosalbutamol acts as a bronchodilator, helping to relax the airway muscles and ease breathing. Guaiphenesin is an expectorant that thins and loosens mucus in the airways, making it easier to expel, while Ambroxol is a mucolytic agent that breaks down thick phlegm and enhances mucociliary clearance. This combination is especially beneficial in managing cough associated with respiratory tract infections, bronchitis, asthma, and COPD.
